A detailed history of Cva Family Office, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Cva Family Office, LLC holds 407 shares of TECH stock, worth $30,472. This represents 0.01% of its overall portfolio holdings.

Number of Shares
407
Previous 407 -0.0%
Holding current value
$30,472
Previous $29,000 10.34%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$62.12 - $84.15 $434 - $589
7 Added 1.75%
407 $29,000
Q4 2023

Jan 16, 2024

BUY
$52.83 - $78.22 $21,132 - $31,288
400 New
400 $30,000
Q2 2023

Jul 10, 2023

BUY
$73.76 - $85.98 $13,276 - $15,476
180 New
180 $14,000
Q4 2022

Feb 21, 2023

SELL
$80.67 - $352.29 $403 - $1,761
-5 Reduced 50.0%
5 $0
Q1 2022

Apr 22, 2022

BUY
$353.85 - $487.79 $3,538 - $4,877
10 New
10 $4,000
Q3 2021

Oct 12, 2021

SELL
$444.87 - $538.88 $6,228 - $7,544
-14 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$387.35 - $450.26 $5,422 - $6,303
14 New
14 $6,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.94B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.